EUVIMEDObjevte EUVIMED
Crossref

2024 leucovorin paper retracted, drug pending FDA approval for cerebral folate deficiency

Alison Knopf

The Brown University Child & Adolescent Psychopharmacology Update · 2026-04 · 28 (4) · 7-7

DOI: 10.1002/cpu.31055 ↗

At a glance

Journal article in The Brown University Child & Adolescent Psychopharmacology Update, published online on 2026-03-23. Written by Alison Knopf.

AbstraktBibliografické údajeCiteRelated studies

Abstract (original language)

Není k dispozici žádný abstrakt.

Cite

APA

Knopf, A. (2026). 2024 leucovorin paper retracted, drug pending FDA approval for cerebral folate deficiency. The Brown University Child & Adolescent Psychopharmacology Update, 28(4), 7-7. https://doi.org/10.1002/cpu.31055

Vancouver

Knopf A. 2024 leucovorin paper retracted, drug pending FDA approval for cerebral folate deficiency. The Brown University Child & Adolescent Psychopharmacology Update. 2026;28(4):7-7. doi:10.1002/cpu.31055

BibTeX
@article{Knopf2026,
  author = {Knopf, Alison},
  title = {2024 leucovorin paper retracted, drug pending FDA approval for cerebral folate deficiency},
  journal = {The Brown University Child & Adolescent Psychopharmacology Update},
  year = {2026},
  volume = {28},
  number = {4},
  pages = {7--7},
  doi = {10.1002/cpu.31055}
}
Start for free →